Lonza and DSM settle omega-3 patent dispute

- Last updated on GMT

Lonza and DSM end decade-long patent dispute over DHA
Lonza and DSM end decade-long patent dispute over DHA

Related tags: Docosahexaenoic acid

Ingredients giants DSM and Lonza have settled a patent dispute over production of algal-sourced omega-3 oils (DHA) that lasted for almost ten years.

Under the agreement, DSM Nutritional Products becomes Lonza’s supplier for its Schizochytrium-based DHA (docosahexaenoic acid) omega-3 oil.

Matthias Rüsing, global product manager for Lonza’s DHAid said that the global food supplements market would remain the focus for DHAid, not the lucrative and fast-growing infant formula space which DSM dominates via the algae DHA business it paid €800m for in the form of Martek Biosciences at the back end of 2010.

The patent dispute dates back to 2006 when Maryland-based Martek successfully sued Lonza over patent infringement relating to the US activities of the DHA business Lonza had itself just acquired from Celanese-owned Nutrinova late in 2005. It was prevented from marketing DHA there.

The global omega-3 market is estimated at €20bn+ although the US supplements market has been in slight decline in the past couple of years as negative press around some research, as well as sustainability and pricing concerns and a slow economy, have been felt.

Lonza offerings include niacin and L-carnitine.

Related news

Show more

Related products

show more

Bioavailable and Stable Ubiquinol CoQH-CF Softgels

Bioavailable and Stable Ubiquinol CoQH-CF Softgels

Soft Gel Technologies, Inc. | 18-Jul-2018 | Infographic

Soft Gel Technologies, Inc. (SGTI) perfected a formula to keep the reduced form of CoQ10 stable. Our CoQH-CF softgels deliver a solubilized form of Kaneka...

Powerful heart health benefits from aronia

Powerful heart health benefits from aronia

Naturex | 07-Jun-2018 | Technical / White Paper

Aronox® is an extract of aronia that delivers heart health benefits supported by several published peer-reviewed clinical trials, with significant improvements...

Learn how Neumentix™ works for active consumers

Learn how Neumentix™ works for active consumers

Kemin Human Nutrition & Health | 17-May-2018 | Technical / White Paper

New clinical trial data revealed Neumentix improved young recreationally active participants’ cognitive and physical performance after 30 days of supplementation...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars